Transcatheter Mitral Valve Implantation Market Size to Reach USD 4.67 Million by 2027; Industry Compound Annual Growth Rate of 14.4% | Emergen Research

The latest report, titled ‘Global Transcatheter Mitral Valve Implantation Market,’ comprises a profound analysis of the fundamental parameters contributing to the global Transcatheter Mitral Valve Implantation market scenario. The research report provides the reader with an in-depth interpretation of the Transcatheter Mitral Valve Implantation market dynamics, including the crucial drivers, opportunities, threats, and challenges.

The market intelligence report is a prototype of the 360° overview of the global Transcatheter Mitral Valve Implantation industry, shedding light on the estimated market value, share, growth trends, gross revenue, competitive overview, prominent manufacturers and buyers, available product types, and end-use applications.

According to the current analysis of Emergen Research, the global Transcatheter Mitral Valve Implantation Market was valued at USD 1.82 billion in 2019 and is expected to reach USD 4.67 billion by 2027, at a CAGR of 14.4%. Rise frequency of mitral valve diseases, increasing pioneering pipeline devices together with rising elderly population with heart condition is positively driving the growth prospects of the Transcatheter Mitral Valve Implantation (repair and replacement) market in the forecast period. Mitral Regurgitation (MR) is the greatest widespread valve disorder affecting more than 4 million in total in the United States.

Roughly, 250,000 cases of mitral regurgitation are recorded in the United States annually out of which close to 50,000 patients decide to undertake recommended surgery. Transcatheter mitral valve replacement (TMVR) is a substitute therapeutic opportunity which has been enhanced considerably to competently treat severe mitral regurgitation in patients who are exposed to high or prohibitive surgical risks.

In addition to detailed market projections, the authors of the report have assessed the Transcatheter Mitral Valve Implantation industry quantitatively and qualitatively. In this report, we discuss two of the most important components of this report: SWOT analysis and Porter's Five Forces Analysis. These analyses offer a deep insight into the highly competitive scenario of the industry. In this report, the global Transcatheter Mitral Valve Implantation market is analyzed in relation to major regions in the world, such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Other key aspects of regional markets are also examined in the report, such as revenue growth drivers and restraints, production and consumption patterns, changing consumer preferences, and stringent regulatory regulations.

For More Insights, Download a FREE sample @ https://www.emergenresearch.com/request-sample/54

Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter’s 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios. The report also presents the country-wise and region-wise analysis of the Emergen Research and includes a detailed analysis of the key factors affecting the growth of the market.

Report Scope:

Historical Data: 2018-2019

Forecast Period: 2021-2028

CAGR: 5.4%

Base Year: 2020

Number of Pages: 250

Research Report on the Transcatheter Mitral Valve Implantation Market Addresses the Following Key Questions:

• Who are the dominant players of the Transcatheter Mitral Valve Implantation market?
• Which regional market is anticipated to have a high growth rate over the projected period?
• What consumer trends and demands are expected to influence the operations of the market players in the Transcatheter Mitral Valve Implantation market?
• What are the key growth drivers and restraining factors of the Transcatheter Mitral Valve Implantation market?
• What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
• What is the overall impact of the COVID-19 pandemic on the Transcatheter Mitral Valve Implantation market and its key segments?

Key Companies Profiled in the Report are:

Abbott Laboratories, HLT Medical, Neovasc, Edward Lifesciences, Biotronik Private Limited, LivaNova, Colibri Heart Valve, Medtronic, NeoChord, MValve Technologies, Transcatheter Technologies GmbH and Venus Medtech

Further key findings from the report suggest

·       To develop functional (secondary) mitral regurgitation, in March 2019, MitraClip's suggestions to address the secondary MR was expanded and approved by US Food and Drug Administration (FDA). This can be administered in patients with structural changes in the heart (such as enlargement due to heart failure)

·       As mechanical values last long up to approximately 25 years post implant/surgery, mechanical valves segment is anticipated to dominate the industry with a market share of almost, 58.3%

·       Mitral Valve Stenosis dominates the market in terms of market share of approximately 44.1% in 2019. However, Mitral Valve Regurgitation segment in the applications outlook registered highest growth rate of approximately 14.1% owing to rise in conditions of mitral regurgitation and due to expansion of potential techniques for successful surgeries

·       Minneapolis based CardioMech AS, a medical device company is developing a transfemoral, transseptally delivered mitral valve repair technology for which in August 2020, it raised fund worth USD 18.5 million for its first-in-human feasibility trial

·       North America dominated the market in terms of market revenue in 2019. Factors contributing to the largest market share (39.7%) are increasing success rate of surgeries, high employability of technologically advanced medical heart therapy devices and favourable compensation policies among other encouraging scenarios

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/transcatheter-mitral-valve-implantation-market

Market Segmentations of the Transcatheter Mitral Valve Implantation Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the forecast period. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Transcatheter Mitral Valve Implantation market on the basis of product, application, and region:

Segments Covered in this report are:

• Product Outlook (Revenue in Million USD; 2017–2027)
• Mechanical Valves
• Bioprosthetic Tissue (Biological) Valves
• Application Outlook (Revenue in Million USD; 2017–2027)
• Mitral Valve Stenosis
• Mitral Valve Prolapse
• Mitral Valve Regurgitation
• End Use Outlook (Revenue in Million USD; 2017–2027)
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

Regional Landscape section of the Transcatheter Mitral Valve Implantation report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.

The various regions analyzed in the report include:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Transcatheter Mitral Valve Implantation market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others

Key reasons to buy the Global Transcatheter Mitral Valve Implantation Market report:

1. The latest report comprehensively studies the global Transcatheter Mitral Valve Implantation market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.
2. The report offers an insightful analysis of the regional outlook of the market.
3. It offers a detailed account of the end-use applications of the products & services offered by this industry.
4. The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request for Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/54

Thank you for reading our report. To know more about the customization feature, please get in touch with us, and our team will ensure the report is customized to meet your requirements.  

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services